89524-63-0

Basic information

• Product Name: 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid
• CAS NO: 89524-63-0
• Molecular Formula: C11H5ClF3NO2
• Molecular Weight: 275.6111096
• Mol File: 89524-63-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid(89524-63-0)
• EPA Substance Registry System: 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid(89524-63-0)

Safety Data

• Hazardous Substances Data: 89524-63-0(Hazardous Substances Data)

Usage

General Description

4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid is a chemical compound with the molecular formula C11H5ClF3NO2. It is a derivative of quinoline and contains a carboxylic acid functional group. 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid has potential applications in the pharmaceutical industry, specifically in the development of new drugs. Its unique structure and properties make it a valuable target for medicinal chemistry research, as it may exhibit biological activity and therapeutic potential. The presence of chlorine, fluorine, and the quinoline core also make it a useful building block for the synthesis of other compounds with similar structural motifs. Overall, 4-chloro-7-(trifluoromethyl)quinoline-3-carboxylic acid has the potential to be an important molecule in drug discovery and organic synthesis.

Upstream product

• 108-18-9 diisopropylamine 
• 346-55-4 4-chloro-7-trifluoromethyl quinoline 
• 124-38-9 carbon dioxide 

Relevant articles and documents

Vanilloid receptor ligands and their use in treatments

bis-Bicyclic amides and derivatives thereof and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof

Aromatic azepinones and thiones having the formula STR1 wherein; A is benzene, naphthalene, quinoline or pyridine; B is oxygen or sulfur; E is oxygen, sulfur or STR2 n is 1, 2 or 3; Z is an amino or a heterocyclic nitrogen-containing radical; R is hydrogen, loweralkyl, cycloalkyl or phenylloweralkyl; Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracetylamino, trifluoromethyl, phenyl or phenyl substituted by one to three Y' radicals selected from halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracylamino or trifluoromethyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.